Tag: Clinical Trials
Influences on New NIH Policy for Age Limits in Research Explored
'Inclusion Across the Lifespan' policy eliminates non-risk-justified age limits on research participants
Structural, Clinical Barriers Prevent Cancer Trial Participation
Trial unavailable at patients' institution 55.6 percent of the time; 21.5 percent of patients ineligible
Many Systematic Reviews Do Not Fully Report Adverse Events
Of 146 protocols analyzed, 65 percent fully reported adverse events as intended by the protocol
Comorbidities Adversely Linked to Cancer Trial Participation
Reduction in trial discussions, trial offers, trial participation seen with one or more comorbidities
Few Mandatory Pediatric Postmarketing Studies Completed
33.8 percent of mandatory pediatric postmarketing studies completed during 6.8 years of follow-up
Financial Conflicts of Interest Prevalent Among CPG Authors
Two studies show high prevalence among authors of guidelines on high-dollar meds, in gastroenterology
Barriers to Prostate Cancer Research in Black Men Identified
Mistrust, lack of knowledge, unfavorable attitudes are barriers to genomic testing, study participation
Harvard: Heart Researcher’s Papers Contain Fraudulent Data
31 scientific publications from the laboratory of Piero Anversa contain falsified and/or fabricated data
Accepted Manuscripts Meet More Criteria for Research Reporting
Certain items, such as objectives, translation of risk poorly reported in most observational research
Industry-Funded Trials Often Involve Employees in Studies
Many trials published in high-impact journals involve funder, academic author in study design, reporting
